a probable the pharmacokinetic interaction between abacavir and ethanol was studied in 24 HIV-1-infected male subjects. Each subjects received the following treatments on separate occasions: a single 600-mg dose of abacavir once in a while
it should abacavir causing an increase in overall exposure. Due to the common metabolic pathways of abacavir and ethanol via alcohol dehydrogenase on occasion
EmoticonEmoticon